Journal rankings · indicator year 2019
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2019
Pulmonary and Respiratory Medicine journal rankings 2019
347 ranked journals · Subfield in Medicine
Pulmonary and Respiratory Medicine has 347 ranked journals in 2019. The median journal has an OJR of 0.71, below the world average of 1.00, up 0.03 on 2018; Q1 starts at OJR 1.21. The top three are Neonatology, European Urology, and The Lancet Respiratory Medicine.
Ranks and citation indicators: 2019. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2016–2018, the window the 2019 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery936
- Pulmonary and Respiratory Medicine347
- Public Health, Environmental and Occupational Health299
- Cardiology and Cardiovascular Medicine290
- Oncology234
- Infectious Diseases217
- Epidemiology198
- Endocrinology, Diabetes and Metabolism168
- Neurology164
- Physiology160
- Radiology, Nuclear Medicine and Imaging153
- Psychiatry and Mental health142
Show all 42 subfields
- Orthopedics and Sports Medicine120
- Pediatrics, Perinatology and Child Health103
- Ophthalmology98
- Dermatology96
- Hematology80
- Obstetrics and Gynecology74
- Rheumatology67
- Nephrology58
- Complementary and alternative medicine54
- Pharmacology54
- Reproductive Medicine50
- Emergency Medicine44
- Geriatrics and Gerontology38
- Otorhinolaryngology35
- Rehabilitation34
- Pathology and Forensic Medicine31
- Critical Care and Intensive Care Medicine24
- Genetics24
- Hepatology23
- Immunology and Allergy22
- Urology14
- Anesthesiology and Pain Medicine13
- Gastroenterology7
- Internal Medicine5
- Health Informatics4
- Family Practice3
- Transplantation3
- Biochemistry1
- Anatomy0
- Microbiology0
347 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2018. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2016–2018, the window the 2019 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2016–2018 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2010 to 2019. | Compare |
|---|---|---|---|---|---|---|---|
1NeonatologyKarger Publishers · Switzerland | 4.89Q1 | 13.11 2.87 up from 2018 | 330 | 35% | — | ||
2European UrologyElsevier BV · Switzerland | 4.52Q1 | 9.51 2.27 down from 2018 | 905 | 20% | $5,250 | ||
3The Lancet Respiratory MedicineElsevier BV · Netherlands | 4.51Q1 | 10.93 1.37 up from 2018 | 561 | 55% | $7,280 | ||
4Cochrane Database of Systematic ReviewsElsevier BV · United Kingdom | 3.36Q1 | 7.43 0.79 up from 2018 | 3,656 | 90% | $5,100 | ||
5Seminars in Fetal and Neonatal MedicineElsevier BV · Netherlands | 3.27Q1 | 5.74 1.07 up from 2018 | 189 | 21% | $4,590 | ||
6European Respiratory ReviewOAEuropean Respiratory Society · United Kingdom | 2.97Q1 | 7.90 2.24 up from 2018 | 212 | 100% | — | ||
7Gastric CancerSpringer Science+Business Media · Japan | 2.91Q1 | 5.90 0.82 down from 2018 | 316 | 98% | $3,590 | ||
8American Journal of Respiratory and Critical Care MedicineAmerican Thoracic Society · United States | 2.84Q1 | 6.73 0.16 down from 2018 | 1,733 | 78% | — | ||
9DrugsAdis, Springer Healthcare · New Zealand | 2.79Q1 | 7.92 1.77 up from 2018 | 453 | 38% | $5,990 | ||
10Intensive Care MedicineSpringer Science+Business Media · Germany | 2.64Q1 | 7.21 1.08 up from 2018 | 1,089 | 53% | $5,190 | ||
11Journal of Thoracic OncologyElsevier BV · United States | 2.62Q1 | 5.58 1.61 down from 2018 | 1,026 | 100% | $4,100 | ||
12Modern PathologyElsevier BV · United States | 2.57Q1 | 6.72 0.32 down from 2018 | 564 | 99% | $4,480 | ||
13European Respiratory JournalEuropean Respiratory Society | 2.55Q1 | 6.82 0.60 up from 2018 | 1,657 | 87% | — | ||
14Critical CareOABioMed Central · United Kingdom | 2.52Q1 | 6.09 0.31 down from 2018 | 1,063 | 100% | $4,190 | ||
15Seminars in PerinatologyElsevier BV · United States | 2.48Q1 | 4.03 0.13 up from 2018 | 210 | 16% | $4,370 | ||
16Therapeutic Advances in Chronic DiseaseOASAGE Publishing · United Kingdom | 2.40Q1 | 5.95 1.11 up from 2018 | 55 | 100% | $2,950 | ||
17Biomedicine HubOAKarger Publishers · Switzerland | 2.25Q1 | 5.42 0.46 down from 2018 | 83 | 100% | $1,670 | ||
18The Journal of UrologyLippincott Williams & Wilkins · United States | 2.24Q1 | 4.89 0.26 up from 2018 | 1,215 | 29% | $3,000 | ||
19ThoraxBMJ · United Kingdom | 2.22Q1 | 5.83 0.85 up from 2018 | 725 | 95% | — | ||
20Frontiers in MedicineOAFrontiers Media · Switzerland | 2.13Q1 | 5.12 1.09 up from 2018 | 645 | 100% | $3,801 | ||
21Annals of Intensive CareOASpringer Nature · France | 2.03Q1 | 5.29 0.23 up from 2018 | 364 | 100% | $3,490 | ||
22CHEST JournalElsevier BV · United States | 2.00Q1 | 3.91 0.63 down from 2018 | 1,707 | 36% | $4,160 | ||
23Archives of Disease in Childhood Fetal & NeonatalBMJ · United Kingdom | 1.96Q1 | 4.41 0.99 up from 2018 | 409 | 44% | — | ||
24Clinics in Chest MedicineElsevier BV · United States | 1.93Q1 | 3.18 1.23 down from 2018 | 192 | 22% | $3,350 | ||
25Drugs in ContextOABioExcel Publishing Ltd · United Kingdom | 1.89Q1 | 4.74 3.45 up from 2018 | 70 | 100% | $1,901 | ||
26Advances in Anatomic PathologyLippincott Williams & Wilkins · United States | 1.85Q1 | 5.01 0.86 up from 2018 | 110 | 14% | — | ||
27Advances in TherapyAdis, Springer Healthcare · United Kingdom | 1.84Q1 | 4.61 0.50 up from 2018 | 534 | 71% | $4,790 | ||
28Radiotherapy and OncologyElsevier BV · Netherlands | 1.80Q1 | 4.74 0.14 up from 2018 | 1,138 | 93% | $3,770 | ||
29Annals of Cardiothoracic SurgeryOAAME Publishing Company · Hong Kong SAR China | 1.79Q1 | 3.60 0.19 down from 2018 | 277 | 100% | — | ||
30Current Opinion in Critical CareLippincott Williams & Wilkins · United States | 1.78Q1 | 3.90 0.86 up from 2018 | 257 | 13% | — | ||
31Respiratory ResearchOABioMed Central · United Kingdom | 1.77Q1 | 4.77 0.33 up from 2018 | 631 | 100% | $3,490 | ||
32Annals of the American Thoracic SocietyAmerican Thoracic Society · United States | 1.77Q1 | 4.09 0.72 up from 2018 | 1,033 | 50% | — | ||
33Lung CancerElsevier BV · Netherlands | 1.73Q1 | 4.69 0.17 down from 2018 | 853 | 16% | $3,390 | ||
34Journal of Photochemistry and Photobiology B BiologyElsevier BV · Netherlands | 1.71Q1 | 5.30 0.89 up from 2018 | 1,202 | 11% | $4,110 | ||
35Lung Cancer Targets and TherapyOADove Medical Press · New Zealand | 1.69Q1 | 4.62 1.12 up from 2018 | 56 | 100% | $2,320 | ||
36Gastrointestinal EndoscopyElsevier BV · United States | 1.68Q1 | 4.73 0.71 up from 2018 | 1,154 | 11% | $3,450 | ||
37Prostate Cancer and Prostatic DiseasesSpringer Nature · United Kingdom | 1.68Q1 | 4.16 0.62 down from 2018 | 226 | 45% | $5,190 | ||
38International Journal of Radiation Oncology*Biology*PhysicsElsevier BV · United States | 1.67Q1 | 3.85 0.39 down from 2018 | 1,641 | 53% | $4,130 | ||
39BMJ Open Respiratory ResearchOABMJ · United Kingdom | 1.65Q1 | 4.15 1.14 up from 2018 | 155 | 100% | $2,085 | ||
40European Journal of Vascular and Endovascular SurgeryElsevier BV · United Kingdom | 1.65Q1 | 4.72 0.70 up from 2018 | 703 | 100% | $4,000 | ||
41Journal of Hepato-Biliary-Pancreatic SciencesWiley · Japan | 1.62Q1 | 5.77 2.58 up from 2018 | 220 | 21% | $3,700 | ||
42Respiratory MedicineElsevier BV · United Kingdom | 1.61Q1 | 3.72 0.07 up from 2018 | 741 | 79% | $3,630 | ||
43British Journal of UrologyWiley · United Kingdom | 1.60Q1 | 3.57 0.14 down from 2018 | 972 | 34% | $4,770 | ||
44Occupational and Environmental MedicineBMJ · United Kingdom | 1.59Q1 | 3.90 0.83 up from 2018 | 428 | 88% | — | ||
45Clinical Sarcoma ResearchOASpringer Science+Business Media · United Kingdom | 1.54Q1 | 2.98 1.12 down from 2018 | 65 | 100% | $2,290 | ||
46Minerva Urology and NephrologyEdizioni Minerva Medica · Italy | 1.54Q1 | 3.39 1.16 up from 2018 | 112 | 100% | — | ||
47American Journal of Physiology-Lung Cellular and Molecular PhysiologyAmerican Physical Society · United States | 1.50Q1 | 4.49 0.33 up from 2018 | 585 | 80% | — | ||
48Therapeutic Advances in Respiratory DiseaseOASAGE Publishing · United States | 1.50Q1 | 4.13 0.93 up from 2018 | 111 | 100% | $2,650 | ||
49Urologic Clinics of North AmericaElsevier BV · United States | 1.48Q1 | 2.05 0.46 down from 2018 | 164 | 8% | $3,000 | ||
50Journal of Cystic FibrosisElsevier BV · Netherlands | 1.47Q1 | 4.14 0.93 up from 2018 | 441 | 100% | $4,370 |
Subfields of Medicine, with Pulmonary and Respiratory Medicine highlighted.
- Surgery936
- Pulmonary and Respiratory Medicine347
- Public Health, Environmental and Occupational Health299
- Cardiology and Cardiovascular Medicine290
- Oncology234
- Infectious Diseases217
- Epidemiology198
- Endocrinology, Diabetes and Metabolism168
- Neurology164
- Physiology160
- Radiology, Nuclear Medicine and Imaging153
- Psychiatry and Mental health142
- Orthopedics and Sports Medicine120
- Pediatrics, Perinatology and Child Health103
- Ophthalmology98
- Dermatology96
- Hematology80
- Obstetrics and Gynecology74
- Rheumatology67
- Nephrology58
- Complementary and alternative medicine54
- Pharmacology54
- Reproductive Medicine50
- Emergency Medicine44
- Geriatrics and Gerontology38
- Otorhinolaryngology35
- Rehabilitation34
- Pathology and Forensic Medicine31
- Critical Care and Intensive Care Medicine24
- Genetics24
- Hepatology23
- Immunology and Allergy22
- Urology14
- Anesthesiology and Pain Medicine13
- Gastroenterology7
- Internal Medicine5
- Health Informatics4
- Family Practice3
- Transplantation3
- Biochemistry1
- Anatomy0
- Microbiology0
Journals
Citations made in 2019. Corpus-wide, 83.4% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
103 additional Pulmonary and Respiratory Medicine journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2016–2018, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2019. Publication window: 2016–2018. How these summaries are calculated
- Ranked journals
- 347
- Window papers (baseline)
- 168,770 +7.4% from indicator year 2016
- Median OJR
- 0.710 +3.1% from indicator year 2016
- Rising journals (2025)
- 26
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2016–2018 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 116 | 128 | 133 | 140 | 152 | 172 | 181 | 194 | 199 | 212 | 221 | 236 | 245 | 266 | 283 | 297 | 315 | 324 | 349 | 347 | 353 | 362 | 367 | 367 | 364 | 352 | |
| Window papers (baseline) | 51,191 | 58,101 | 61,730 | 66,053 | 67,282 | 74,504 | 82,746 | 93,558 | 102,120 | 113,728 | 123,057 | 131,093 | 135,018 | 138,763 | 146,389 | 152,077 | 157,160 | 158,971 | 164,168 | 168,770 | 175,931 | 189,625 | 206,647 | 218,275 | 218,995 | 219,470 | |
| Median OJR | 0.56 | 0.57 | 0.55 | 0.628 | 0.671 | 0.663 | 0.713 | 0.664 | 0.693 | 0.70 | 0.767 | 0.80 | 0.84 | 0.768 | 0.75 | 0.731 | 0.689 | 0.6662 | 0.68 | 0.710 | 0.730 | 0.6663 | 0.665 | 0.687 | 0.64 | 0.633 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.